Legal & Compliance - Page 21

Governor Josh Shapiro signed Executive Order 2026-05 on August 18, 2026, titled “Protecting Pennsylvania Consumers from Data Center Impacts,” introducing sweeping new requirements for data centre development across the state. The order

Legal technology was once a quiet, overlooked corner of the business world, where small vendors scraped for funding and innovation moved at a glacial pace. For much of its early history, the

Yahoo has secured a major legal victory after a federal court ruled that five plaintiffs must pursue their privacy claims through arbitration rather than class action litigation. The case, Tyler Baker, et

Justice Clarence Thomas has opened up about his early relationship with fellow Supreme Court Justice Samuel Alito in a rare and candid interview setting. Thomas sat down with Senator Ted Cruz on

Kara Maciel always knew she wanted to be a lawyer, and a high school trip to Washington, DC was the moment that made it certain. What she did not anticipate was one

California’s Division of Occupational Safety and Health has released a discussion draft proposing major amendments to its heat illness prevention standards under Assembly Bill 2243. The proposed changes would affect both outdoor

Without binding federal legislation covering all 50 states, noncompete agreements remain firmly governed by individual state laws across the country. This legal fragmentation means employers operating in multiple states face a complex

The legal profession has undergone a quiet but significant shift in professional dress standards since the COVID-19 pandemic changed how lawyers work. Before the pandemic, attorneys operated within well-established expectations about appropriate

The battle over mail-in ballot rules has returned to its starting point, with a federal judge once again freezing the contested Postal Service regulation. The Supreme Court had lifted an earlier injunction

The D.C. Circuit has delivered a significant ruling on how pharmaceutical companies can lose their 180-day market exclusivity periods for generic drugs, raising the bar for what counts as a valid excuse.